{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:31:17Z","timestamp":1790447477423,"version":"4.1.0"},"reference-count":172,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.lfs.2005.12.010","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T15:34:01Z","timestamp":1138376041000},"page":"2131-2145","source":"Crossref","is-referenced-by-count":205,"title":["MDR- and CYP3A4-mediated drug\u2013herbal interactions"],"prefix":"10.1016","volume":"78","author":[{"given":"Dhananjay","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashim K.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0944-7113(00)80029-X","article-title":"Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology","volume":"7","author":"Agrosi","year":"2000","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2005.12.010_bb0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"47","key":"10.1016\/j.lfs.2005.12.010_bb0015","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","article-title":"P-glycoprotein: from genomics to mechanism","volume":"22","author":"Ambudkar","year":"2003","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.lfs.2005.12.010_bb0020","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jama.279.19.1548","article-title":"Why patients use alternative medicine: results of a national study","volume":"279","author":"Astin","year":"1998","journal-title":"JAMA"},{"issue":"8\u20139","key":"10.1016\/j.lfs.2005.12.010_bb0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/00498250110060969","article-title":"Role of transport proteins in drug absorption, distribution and excretion","volume":"31","author":"Ayrton","year":"2001","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2125.1998.00764.x","article-title":"Grapefruit juice\u2013drug interactions","volume":"46","author":"Bailey","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/026988110001400113","article-title":"Mania in a patient receiving testosterone replacement postorchidectomy taking St. John's wort and sertraline","volume":"14","author":"Barbenel","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.lfs.2005.12.010_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00007890-200101270-00012","article-title":"Herbal supplements: a potential for drug interactions in transplant recipients","volume":"71","author":"Barone","year":"2001","journal-title":"Transplatation"},{"issue":"28","key":"10.1016\/j.lfs.2005.12.010_bb0045","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1021\/bi00143a002","article-title":"Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate","volume":"31","author":"Bates","year":"1992","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1023\/A:1012879205914","article-title":"The role of half-transporters in multidrug resistance","volume":"33","author":"Bates","year":"2001","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.lfs.2005.12.010_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2125.2003.01759.x","article-title":"Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients","volume":"55","author":"Bauer","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0060","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1592\/phco.20.6.568.35152","article-title":"Consumer use of St. John's wort: a survey on effectiveness, safety, and tolerability","volume":"20","author":"Beckman","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2005.12.010_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-979344","article-title":"Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers","volume":"31","author":"Biber","year":"1998","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0070","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjp.0703920","article-title":"HMG-CoA reductase inhibitors and P-glycoprotein modulation","volume":"132","author":"Bogman","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2005.12.010_bb0075","first-page":"535","article-title":"Johanniskraut: ein enzymindultor?","volume":"16","author":"Bon","year":"1999","journal-title":"Schweitzer Apothekerzeitung"},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0080","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/bjc.1996.673","article-title":"Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity","volume":"74","author":"Bokemeyer","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0952-3278(98)90034-5","article-title":"Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease","volume":"58","author":"Bordia","year":"1998","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"16","key":"10.1016\/j.lfs.2005.12.010_bb0090","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","article-title":"A family of drug transporters: the multidrug resistance-associated proteins","volume":"92","author":"Borst","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/toxsci\/66.1.27","article-title":"St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse","volume":"66","author":"Bray","year":"2002","journal-title":"Toxicol. Sci."},{"issue":"9218","key":"10.1016\/j.lfs.2005.12.010_bb0100","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/S0140-6736(05)73359-6","article-title":"Drug interaction of St. John's wort with cyclosporin","volume":"355","author":"Breidenbach","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2005.12.010_bb0105","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1097\/00007890-200005270-00052","article-title":"Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum)","volume":"69","author":"Breidenbach","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.lfs.2005.12.010_bb0110","series-title":"Herb Contraindications and Drug Interactions","author":"Brinker","year":"1998"},{"key":"10.1016\/j.lfs.2005.12.010_bb0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00006534-199501000-00060","article-title":"Garlic as a possible risk for post-operative bleeding","volume":"95","author":"Burnham","year":"1995","journal-title":"Plastic Reconstr. Surg."},{"issue":"8","key":"10.1016\/j.lfs.2005.12.010_bb0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/jnci\/85.8.632","article-title":"Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs","volume":"85","author":"Chaudhary","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2005.12.010_bb0125","first-page":"658","article-title":"Ginkgo (part 1): history, use, and pharmacologic properties","volume":"33","author":"Chavez","year":"1998","journal-title":"Hosp. Pharm."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0092-8674(86)90595-7","article-title":"Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells","volume":"47","author":"Chen","year":"1986","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0135","first-page":"307","article-title":"Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor","volume":"24","author":"Chiba","year":"1996","journal-title":"Drug Metab. Dispos."},{"issue":"19","key":"10.1016\/j.lfs.2005.12.010_bb0140","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0024-3205(95)02152-9","article-title":"Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes","volume":"57","author":"Chieli","year":"1995","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.lfs.2005.12.010_bb0145","first-page":"361","article-title":"Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells","volume":"1","author":"Chin","year":"1990","journal-title":"Cell Growth Differ."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0021-9258(19)40219-6","article-title":"Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells","volume":"265","author":"Chin","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"5043","key":"10.1016\/j.lfs.2005.12.010_bb0155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1346476","article-title":"Modulation of activity of the promoter of the human MDR1 gene by Ras and p53","volume":"255","author":"Chin","year":"1992","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.lfs.2005.12.010_bb0160","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1023\/A:1007570517183","article-title":"Potential role of P-glycoprotein in affecting hepatic metabolism of drugs","volume":"17","author":"Chiou","year":"2000","journal-title":"Pharm. Res."},{"issue":"5088","key":"10.1016\/j.lfs.2005.12.010_bb0165","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0170","first-page":"213","article-title":"Involvement of the transcription factor NF-IL6 in phorbol ester induction of P-glycoprotein in U937 cells","volume":"8","author":"Combates","year":"1997","journal-title":"Cell Growth Differ."},{"issue":"8","key":"10.1016\/j.lfs.2005.12.010_bb0175","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0090-9556(24)15235-X","article-title":"OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine","volume":"27","author":"Cvetkovic","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/026988110201600420","article-title":"Possible serotonin syndrome after combination of buspirone and St. John's wort","volume":"16","author":"Dannawi","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.lfs.2005.12.010_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1309\/P024K7VRDDPJCTVN","article-title":"Review of abnormal laboratory test results and toxic effects due to use of herbal medicines","volume":"120","author":"Dasgupta","year":"1990","journal-title":"Am .J. Clin. Pathol."},{"issue":"7","key":"10.1016\/j.lfs.2005.12.010_bb0190","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/js980029p","article-title":"Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions","volume":"87","author":"Decker","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/scbi.1997.0070","article-title":"Function, evolution and structure of multidrug resistance protein (MRP)","volume":"8","author":"Deeley","year":"1997","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0593-42","article-title":"Gain of function mutations in p53","volume":"4","author":"Dittmer","year":"1993","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2003.27","article-title":"P-glycoprotein-mediated intestinal and biliary digoxin transport in humans","volume":"73","author":"Drescher","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mcp.2003.10","article-title":"Coordinate induction of both cytochrome P4503A and MDR1 by St. John's wort in healthy subjects","volume":"73","author":"Dresser","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0215","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mcp.2000.112240","article-title":"St. John's wort induces intestinal P-glycoprotein\/MDR1 and intestinal and hepatic CYP3A4","volume":"68","author":"Durr","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0220","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mcp.2000.112240","article-title":"St. John's wort induces intestinal P-glycoprotein\/MDR1 and intestinal and hepatic CYP3A4","volume":"68","author":"Durr","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0225","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7326\/0003-4819-135-3-200108070-00014","article-title":"Complementary and alternative medicine\u2014an Annals series","volume":"135","author":"Eisenberg","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0002-9343(97)00397-5","article-title":"Harmless herbs? A review of the recent literature","volume":"104","author":"Ernst","year":"1998","journal-title":"Am. J. Med."},{"issue":"9195","key":"10.1016\/j.lfs.2005.12.010_bb0235","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0140-6736(99)00418-3","article-title":"Second thoughts about safety of St. John's wort","volume":"354","author":"Ernst","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00007691-200002000-00028","article-title":"Influence of dietary components on the gastrointestinal metabolism and transport of drugs","volume":"22","author":"Evans","year":"2000","journal-title":"Ther. Drug Monit."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2005.12.010_bb0245","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1055\/s-2001-15462","article-title":"Inhibition of substance P-induced cytokine synthesis by St. John's wort extracts","volume":"34","author":"Fiebich","year":"2001","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0250","first-page":"256","article-title":"Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism","volume":"25","author":"Fitzsimmons","year":"1997","journal-title":"Drug Metab. Dispos."},{"issue":"9198","key":"10.1016\/j.lfs.2005.12.010_bb0255","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(99)06457-0","article-title":"Herb\u2013drug interactions","volume":"355","author":"Fugh-Berman","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0260","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.0306-5251.2001.01469.x","article-title":"Herb\u2013drug interactions: review and assessment of report reliability","author":"Fugh-Berman","year":"2001","journal-title":"Br. J. Clin. Pharmacol.Vol nr 52"},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00002018-199818040-00002","article-title":"Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance","volume":"18","author":"Fuhr","year":"1998","journal-title":"Drug Safety"},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/oxfordjournals.ndt.a027066","article-title":"Cisplatin nephrotoxicity and protection by silibinin","volume":"11","author":"Gaedeke","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2125.2003.01736.x","article-title":"Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers","volume":"55","author":"Gallicano","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0280","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0026-895X(24)12603-X","article-title":"Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor","volume":"60","author":"Goodwin","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0285","first-page":"950","article-title":"SSRIs and St. John's wort: possible toxicity?","volume":"57","author":"Gordon","year":"1998","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.lfs.2005.12.010_bb0290","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.bi.62.070193.002125","article-title":"Biochemistry of multidrug resistance mediated by the multidrug transporter","volume":"62","author":"Gottesman","year":"1993","journal-title":"Annu. Rev. Biochem."},{"issue":"11","key":"10.1016\/j.lfs.2005.12.010_bb0295","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1016\/S0021-9258(19)89213-X","article-title":"Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism","volume":"261","author":"Guengerich","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0300","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1254\/jjp.82.122","article-title":"Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity","volume":"82","author":"Guo","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0305","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2125.1995.tb04455.x","article-title":"Metabolism of theophylline by cDNA-expressed human cytochromes P-450","volume":"39","author":"Ha","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0310","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/pr.55.4.2","article-title":"Induction of drug metabolism: the role of nuclear receptors","volume":"55","author":"Handschin","year":"2003","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0021-9150(88)90244-4","article-title":"Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia","volume":"74","author":"Harenberg","year":"1988","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0320","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.0306-5251.2001.01516.x","article-title":"St Johns wort increases expression of P-glycoprotein: implications for drug interactions","volume":"53","author":"Hennessy","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0325","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00003088-199835040-00002","article-title":"Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents","volume":"35","author":"Hsu","year":"1998","journal-title":"Clin. Pharmacokinet."},{"issue":"6282","key":"10.1016\/j.lfs.2005.12.010_bb0330","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/346362a0","article-title":"Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport","volume":"346","author":"Hyde","year":"1990","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0335","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/00498250210124147","article-title":"Pharmacokinetic interactions between herbal remedies and medicinal drugs","volume":"32","author":"Ioannides","year":"2002","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0340","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0031-6997(24)01372-3","article-title":"Prediction of pharmacokinetic alterations caused by drug\u2013drug interactions: metabolic interaction in the liver","volume":"50","author":"Ito","year":"1998","journal-title":"Pharmacol. Rev."},{"issue":"15","key":"10.1016\/j.lfs.2005.12.010_bb0345","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200161150-00002","article-title":"Interactions between herbal medicines and prescribed drugs: a systematic review","volume":"61","author":"Izzo","year":"2001","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0350","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/ajhp\/54.6.692","article-title":"Probable interaction between warfarin and ginseng","volume":"54","author":"Janetzky","year":"1997","journal-title":"Am. J. Health-Syst. Pharm."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0355","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/cp.1999.v66.a101944","article-title":"Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum)","volume":"66","author":"Johne","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0360","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00004714-200202000-00008","article-title":"Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort (Hypericum perforatum)","volume":"22","author":"Johne","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"20","key":"10.1016\/j.lfs.2005.12.010_bb0365","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/jnci\/92.20.1651","article-title":"Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan","volume":"92","author":"Jonker","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0370","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0375","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(96)00140-4","article-title":"Human P450 metabolism of warfarin","volume":"73","author":"Kaminsky","year":"1997","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0380","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0168-8278(00)80321-9","article-title":"Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation","volume":"33","author":"Karliova","year":"2000","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0385","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0928-0987(00)00215-3","article-title":"Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport","volume":"12","author":"Katoh","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0390","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2125.2004.02171.x","article-title":"Drug interaction between St. John's wort and quazepam","volume":"58","author":"Kawaguchi","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0395","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0952-8180(00)00195-1","article-title":"Herbal medicines: current trends in anesthesiology practice\u2014a hospital survey","volume":"12","author":"Kaye","year":"2000","journal-title":"J. Clin. Anesth."},{"issue":"11","key":"10.1016\/j.lfs.2005.12.010_bb0400","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0006-2952(94)90071-X","article-title":"Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation","volume":"47","author":"Kerr","year":"1994","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0405","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-135-4-200108210-00011","article-title":"Long-term trends in the use of complementary and alternative medical therapies in the United States","volume":"135","author":"Kessler","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0410","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0022-3565(24)37742-0","article-title":"Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein","volume":"286","author":"Kim","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0415","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2000-9388","article-title":"Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters","volume":"20","author":"Kipp","year":"2000","journal-title":"Semin. Liver Dis."},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0420","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI116064","article-title":"Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes","volume":"90","author":"Kolars","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0425","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/clpt.1988.87","article-title":"Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs","volume":"43","author":"Kronbach","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0430","first-page":"423","article-title":"Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes","volume":"277","author":"Kumar","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.lfs.2005.12.010_bb0435","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1472-8206.1991.tb00746.x","article-title":"Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes","volume":"5","author":"Lacarelle","year":"1991","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0440","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/089198879901200103","article-title":"St. John's wort and antidepressant drug interactions in the elderly","volume":"12","author":"Lantz","year":"1999","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0445","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0026-895X(24)26438-5","article-title":"Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1\/P-glycoprotein","volume":"57","author":"Lecureur","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0450","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1440-1681.1987.tb01510.x","article-title":"Effects of Panax ginseng on blood alcohol clearance in man","volume":"14","author":"Lee","year":"1987","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0455","first-page":"119","article-title":"Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects","volume":"43","author":"Legnani","year":"1993","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0460","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0300-483X(01)00454-1","article-title":"Toxicological relevance of the multidrug resistance protein 1 MRP1 (ABCC1) and related transporters","volume":"167","author":"Leslie","year":"2001","journal-title":"Toxicology"},{"issue":"1\u20133","key":"10.1016\/j.lfs.2005.12.010_bb0465","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(99)00021-6","article-title":"Transport, metabolism and elimination mechanisms of anti-HIV agents","volume":"39","author":"Li","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0470","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.lfs.2005.12.010_bb0475","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/PL00000912","article-title":"From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance","volume":"58","author":"Litman","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.lfs.2005.12.010_bb0480","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/dmd.30.7.763","article-title":"Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1","volume":"30","author":"Luo","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0485","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00002018-199920020-00005","article-title":"Drug interactions of HIV protease inhibitors","volume":"20","author":"Malaty","year":"1999","journal-title":"Drug Safety"},{"issue":"9","key":"10.1016\/j.lfs.2005.12.010_bb0490","doi-asserted-by":"crossref","first-page":"PL133","DOI":"10.1016\/S0024-3205(99)00659-1","article-title":"Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers","volume":"66","author":"Markowitz","year":"2000","journal-title":"Life Sci."},{"issue":"16","key":"10.1016\/j.lfs.2005.12.010_bb0495","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/94.16.1247","article-title":"Effects of St. John's wort on irinotecan metabolism","volume":"94","author":"Mathijssen","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2005.12.010_bb0500","first-page":"A22","article-title":"Interaction of St. John's wort extract with phenprocoumon","volume":"55","author":"Mauer","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0505","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1517\/14622416.2.4.401","article-title":"Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs","volume":"2","author":"Mitra","year":"2001","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0510","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0006-291X(92)91248-O","article-title":"Activation of human multidrug resistance-1 gene promoter in response to heat shock stress","volume":"187","author":"Miyazaki","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.lfs.2005.12.010_bb0515","first-page":"1347","article-title":"The involvement of cytochrome P450 3A4 in the N-demethylation of l-alpha-acetylmethadol (LAAM), norLAAM, and methadone","volume":"25","author":"Moody","year":"1997","journal-title":"Drug Metab. Dispos."},{"issue":"13","key":"10.1016\/j.lfs.2005.12.010_bb0520","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1073\/pnas.130155097","article-title":"St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor","volume":"97","author":"Moore","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0525","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jat.2550120613","article-title":"Silymarin protects against paracetamol-induced lipid peroxidation and liver damage","volume":"12","author":"Muriel","year":"1992","journal-title":"J. Appl. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0530","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1345\/aph.18252","article-title":"Potential metabolic interaction between St. John's wort and theophylline","volume":"33","author":"Nebel","year":"1999","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0535","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3565(24)39043-3","article-title":"Inhibition of human cytochrome P450 enzymes by constituents of St. John's wort, an herbal preparation used in the treatment of depression","volume":"294","author":"Obach","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0540","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/bi991943f","article-title":"Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60\/VCR human acute myeloid leukemia cell line","volume":"39","author":"Ogretmen","year":"2000","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0545","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000139533","article-title":"Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes","volume":"55","author":"Olesen","year":"1997","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0550","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/070674370104600112","article-title":"Adverse reactions to St. John's wort","volume":"46","author":"Parker","year":"2001","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0555","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/019262339602400107","article-title":"An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials","volume":"24","author":"Parkinson","year":"1996","journal-title":"Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0560","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.mjt.0000101827.94820.22","article-title":"In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity","volume":"11","author":"Patel","year":"2004","journal-title":"Am. J. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0565","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1517\/14622416.2.4.401","article-title":"Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs","volume":"2","author":"Patel","year":"2001","journal-title":"Pharmacogenomics"},{"issue":"5252","key":"10.1016\/j.lfs.2005.12.010_bb0570","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1126\/science.271.5252.1126","article-title":"Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene","volume":"271","author":"Paulusma","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0575","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/hep.510250635","article-title":"A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome","volume":"25","author":"Paulusma","year":"1997","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.lfs.2005.12.010_bb0580","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.bjp.0704399","article-title":"Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure","volume":"134","author":"Perloff","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"9203","key":"10.1016\/j.lfs.2005.12.010_bb0585","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(99)05712-8","article-title":"Indinavir concentrations and St. John's wort","volume":"355","author":"Piscitelli","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0590","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/324351","article-title":"The effect of garlic supplements on the pharmacokinetics of saquinavir","volume":"34","author":"Piscitelli","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0595","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1592\/phco.22.8.551.33205","article-title":"Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers","volume":"22","author":"Piscitelli","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.lfs.2005.12.010_bb0600","first-page":"1191","article-title":"In vitro metabolism of simvastatin in humans [SBT] identification of metabolizing enzymes and effect of the drug on hepatic P450s","volume":"25","author":"Prueksaritanont","year":"1997","journal-title":"Drug Metab. Dispos."},{"issue":"11\u201312","key":"10.1016\/j.lfs.2005.12.010_bb0605","doi-asserted-by":"crossref","first-page":"583","DOI":"10.5694\/j.1326-5377.1998.tb123424.x","article-title":"Hypericum perforatum (St. John's wort) in depression: pest or blessing?","volume":"169","author":"Rey","year":"1998","journal-title":"Med. J. Aust."},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0610","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1067\/mcp.2000.106793","article-title":"St. John's wort: effect on CYP3A4 activity","volume":"67","author":"Roby","year":"2000","journal-title":"Clin .Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2005.12.010_bb0615","first-page":"14","article-title":"Drug interactions with Hypericum. Is nature not so mild after all? Interview by Petra Eiden","volume":"142","author":"Roots","year":"2000","journal-title":"MMW Fortschr. Med."},{"key":"10.1016\/j.lfs.2005.12.010_bb0620","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1227\/00006123-199005000-00026","article-title":"Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report","volume":"26","author":"Rose","year":"1990","journal-title":"Neurosurgery"},{"key":"10.1016\/j.lfs.2005.12.010_bb0625","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJM199704103361518","article-title":"Spontaneous hyphema associated with ingestion of Ginkgo biloba extract","volume":"336","author":"Rosenblatt","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"9203","key":"10.1016\/j.lfs.2005.12.010_bb0630","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0140-6736(99)05467-7","article-title":"Acute heart transplant rejection due to Saint John's wort","volume":"355","author":"Ruschitzka","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0635","first-page":"2012","article-title":"Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans","volume":"6","author":"Santos","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0640","first-page":"31","article-title":"Characterization of human liver cytochromes P-450 involved in theophylline metabolism","volume":"20","author":"Sarkar","year":"1992","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0645","first-page":"65","article-title":"Efficacy and safety of the standardised ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]","volume":"22","author":"Scaglione","year":"1996","journal-title":"Drugs Exp. Clin. Res."},{"issue":"10","key":"10.1016\/j.lfs.2005.12.010_bb0650","first-page":"537","article-title":"Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer","volume":"16","author":"Scaglione","year":"1990","journal-title":"Drugs Exp. Clin. Res."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0655","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00685655","article-title":"Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target","volume":"34","author":"Scambia","year":"1994","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0660","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A","volume":"96","author":"Schinkel","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0665","first-page":"117","article-title":"Transcription of the multidrug resistance gene MDR1: a therapeutic target","volume":"1","author":"Scotto","year":"2001","journal-title":"Mol. Interv."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0670","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0006-2952(96)00826-X","article-title":"Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein","volume":"53","author":"Shapiro","year":"1997","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0675","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s002329900305","article-title":"The P-glycoprotein efflux pump: how does it transport drugs?","volume":"160","author":"Sharom","year":"1997","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.lfs.2005.12.010_bb0680","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0773.1983.tb01879.x","article-title":"Influence of dithiocarb, (+)-catechin and silybine on halothane hepatotoxicity in the hypoxic rat model","volume":"53","author":"Siegers","year":"1983","journal-title":"Acta Pharm. Toxicol. (Copenh.)"},{"issue":"10","key":"10.1016\/j.lfs.2005.12.010_bb0685","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2337\/diacare.18.10.1373","article-title":"Ginseng therapy in non-insulin-dependent diabetic patients","volume":"18","author":"Sotaniemi","year":"1995","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0690","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/02699050110103319","article-title":"Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury","volume":"16","author":"Spinella","year":"2002","journal-title":"Brain Inj."},{"issue":"5","key":"10.1016\/j.lfs.2005.12.010_bb0695","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/87912","article-title":"The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux","volume":"7","author":"Synold","year":"2001","journal-title":"Nat. Med."},{"issue":"21","key":"10.1016\/j.lfs.2005.12.010_bb0700","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.lfs.2005.12.010_bb0705","doi-asserted-by":"crossref","first-page":"11037","DOI":"10.1073\/pnas.94.20.11037","article-title":"p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents","volume":"94","author":"Thottassery","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2005.12.010_bb0710","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.38.1.389","article-title":"In vitro and in vivo drug interactions involving human CYP3A","volume":"38","author":"Thummel","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0715","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1023\/A:1016100715125","article-title":"Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates","volume":"19","author":"Tian","year":"2002","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.lfs.2005.12.010_bb0720","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1073\/pnas.84.9.3004","article-title":"Expression of a full-length cDNA for the human \u201cMDR1\u201d gene confers resistance to colchicine, doxorubicin, and vinblastine","volume":"84","author":"Ueda","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0725","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)81370-7","article-title":"MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine","volume":"87","author":"van Helvoort","year":"1996","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0730","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003088-199834030-00002","article-title":"Saquinavir. Clinical pharmacology and efficacy","volume":"34","author":"Vella","year":"1998","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0735","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/j.1552-4604.1998.tb04399.x","article-title":"Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4","volume":"38","author":"Venkatakrishnan","year":"1998","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0740","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/00912709922008173","article-title":"Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs","volume":"39","author":"Venkatakrishnan","year":"1999","journal-title":"J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.lfs.2005.12.010_bb0745","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1177\/00912700122012634","article-title":"Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies","volume":"41","author":"Venkatakrishnan","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2005.12.010_bb0750","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s000180050111","article-title":"Silibinin, a plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancreas from cyclosporin A toxicity","volume":"53","author":"von Schonfeld","year":"1997","journal-title":"Cell Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.lfs.2005.12.010_bb0755","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.160.7.1009","article-title":"American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus","volume":"160","author":"Vuksan","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2005.12.010_bb0760","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00126-5","article-title":"Active secretion and enterocytic drug metabolism barriers to drug absorption","volume":"46","author":"Wacher","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.lfs.2005.12.010_bb0765","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/js980082d","article-title":"Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics","volume":"87","author":"Wacher","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0770","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mc.2940130302","article-title":"Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy","volume":"13","author":"Wacher","year":"1995","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0775","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0009-9236(01)17221-8","article-title":"The effects of St. John's wort (Hypericum perforatum) on human cytochrome P450 activity","volume":"70","author":"Wang","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0780","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1067\/mcp.2002.124080","article-title":"Effect of St. John's wort on the pharmacokinetics of fexofenadine","volume":"71","author":"Wang","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0785","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00042560-199811010-00001","article-title":"Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells","volume":"19","author":"Washington","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Human Retrovirol."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2005.12.010_bb0790","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0169-409X(97)00041-0","article-title":"The barrier function of CYP3A4 and P-glycoprotein in the small bowel","volume":"27","author":"Watkins","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2005.12.010_bb0795","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI113156","article-title":"Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man","volume":"80","author":"Watkins","year":"1987","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.lfs.2005.12.010_bb0800","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0046-8177(90)90073-E","article-title":"P-glycoproteins in pathology: the multidrug resistance gene family in humans","volume":"21","author":"Weinstein","year":"1990","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.lfs.2005.12.010_bb0805","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1677\/joe.0.166R011","article-title":"St. John's wort, a herbal antidepressant, activates the steroid X receptor","volume":"166","author":"Wentworth","year":"2000","journal-title":"J. Endocrinol."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2005.12.010_bb0810","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0169-409X(97)00040-9","article-title":"The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans","volume":"27","author":"Wilkinson","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2005.12.010_bb0815","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0169-409X(99)00027-7","article-title":"Oral absorption of the HIV protease inhibitors: a current update","volume":"39","author":"Williams","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.lfs.2005.12.010_bb0820","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1177\/00912709922012006","article-title":"The contribution of P-glycoprotein to pharmacokinetic drug\u2013drug interactions","volume":"39","author":"Yu","year":"1999","journal-title":"J. Clin. Pharmacol."},{"issue":"9203","key":"10.1016\/j.lfs.2005.12.010_bb0825","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0140-6736(05)73227-X","article-title":"Safety of St. John's wort (Hypericum perforatum)","volume":"355","author":"Yue","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0830","first-page":"1529","article-title":"The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53","volume":"8","author":"Zastawny","year":"1993","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.lfs.2005.12.010_bb0835","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1023\/B:PHAM.0000033015.84146.4c","article-title":"Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport","volume":"21","author":"Zhang","year":"2004","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.lfs.2005.12.010_bb0840","first-page":"779","article-title":"Effect of differentiating agents on modulation of MDR1 gene expression in multidrug-resistant hematopoietic HL60\/DNR cell line","volume":"21","author":"Zhou","year":"1993","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.lfs.2005.12.010_bb0845","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/0269881104042632","article-title":"Pharmacokinetic interactions of drugs with St. John's wort","volume":"18","author":"Zhou","year":"2004","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2005.12.010_bb0850","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2001","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.lfs.2005.12.010_bb0855","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08860229809045136","article-title":"The effect of silibinin on experimental cyclosporine nephrotoxicity","volume":"20","author":"Zima","year":"1998","journal-title":"Ren. Fail."},{"issue":"13","key":"10.1016\/j.lfs.2005.12.010_bb0860","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0024-3205(02)01913-6","article-title":"Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity","volume":"71","author":"Zou","year":"2002","journal-title":"Life Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320505012452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320505012452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T14:23:47Z","timestamp":1736259827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320505012452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":172,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0024320505012452"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2005.12.010","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}